Cellular Growth  Tech to translate  Making it
Leonardo Royal Hotel London Tower Bridge
20 October 2022
Advanced Therapies Integrates Speakers 2022
MATTHEW DURDY
Chief Executive Officer
Cell and Gene Therapy Catapult
MARTIN MURPHY
Chief Executive Officer
Syncona Investment Management
JASON MELLAD
Chief Executive Officer
Start Codon
SHARON BROWNLOW
Chief Business Officer
Cell & Gene Therapy Catapult
JOE HEALEY
Chief Executive Officer and
Co-Founder
NanoSyrinx
FRANCESCA GLIUBICH
Director
London Advanced Therapies
SAM GOLDSMITH
Senior Commercialisation of Research Manager
Cell and Gene Therapy Catapult
ERIC HALIOUA
President & Chief Executive Officer
PDC*line Pharma
JAMES KUSENA
Vice President of Bioprocessing and Applications
MicrofluidX
LEE DUNHAM
Head of Collaboration
Cell and Gene Therapy Catapult
MIGUEL FORTE
Chief Executive Officer
Bone Therapeutics
JENNY LAIRD
Vice President, Search & Evaluation Pain & Neurodegeneration
Eli Lilly and Company
MOIN SALEEM
Professor of Paediatric Renal Medicine
University of Bristol
RAJ MEHTA
Entrepreneur in Residence
Apple Tree Partners
TERRI GASKELL
Chief Technical Officer
Rinri Therapeutics Ltd
NATHAN SIGWORTH
Co-founder and Chief Executive Officer
CCX
KERSTIN PAPENFUSS
Associate Director Therapeutics
Deep Science Ventures
STEFANOS THEOHARIS
Independent Expert
Former Bone Therapeutics SA
NICK STEPHENS
Executive Chairman
The RSA Group
WILLIAM (BILL) SCOTT
Scientific Director, Transplant Regenerative Medicine
Newcastle University Medical School
SIMON CHANDLER
Chief Executive Officer
Rinri Therapeutics
FLIC GABBAY
Founding & Senior Partner
tranScrip
KIRSTY WYDENBACH
Head of Regulatory Strategy
Weatherden
LEE CONEY
Head of Non-Clinical Safety
Cell and Gene Therapy Catapult
MUSTAFA MUNYE
Director of R&D Operations
Complement Therapeutics
MARCELO BRAVO
Co Founder & Chief Executive Officer
OXVax
ANTOINE ESPINET
Co Founder & Chief Executive Officer
MicrofluidX
FREDDIE DEAR
Head of Corporate Development & Portfolio Manager
Ascend Gene & Cell Therapies
ANGELA OSBORNE
Chief Executive Officer
eXmoor pharma concepts
DOMINIC SCHMIDT
General Partner
Advent Life Sciences
IAN ANDERSON
Global Senior Principal Scientist, Global Biologics
Lonza
CHRIS BAKER
Investment Principal
LifeArc Ventures
OLIVER SEXTON
Investment Director
UKI2S
GAURAV VENKATARAMAN
Cofounder and Chief Executive Officer
Trisk Bio
PANOS KEFALAS
Director of the Access Strategy Group
Cell and Gene Therapy Catapult
BRIAN MULLAN
Chief Technical Officer
Cell and Gene Therapies, Yposkesi
NEELAM PANCHAL
Senior Commercialisation of Research Scientist
Cell and Gene Therapy Catapult
AGATHE GUILLOT
Senior Regulatory Consultant
DLRC
CATRIONA CROMBIE
Associate Director: Technology Transfer and Philanthropic Fund Manager
LifeArc
KWOK PANG
COO and Co-Founder
Autolomous
JOHN LIDDELL
Chief Technologist
CPI Biologics
NICOLA REDFERN
Consultant
NJ Redfern Ltd
PAUL CATCHPOLE
Value & Access Policy Director
ABPI
JIMMY MCBLANE
Preclinical Assessor
MHRA
STEVE KAPPENTHULER
Chief Business Officer and Co-founder
Muvon Therapeutics
VERITY NANCOLLIS
Associate Director BDM&C
Pharmaron
JESÚS ZURDO
Global Head Cell, Gene Therapy & Bioproduction
Horizon Discovery
MICHAEL BAKER
Senior Director, Viral Gene Therapy
FUJIFILM Diosynth Biotechnologies
RUI SOUSA
Co-founder and CEO
Stemmatters
DAVID GRIFFITHS-JOHNSON
Head of Manufacturing
Office for Life Sciences
LAURA BESWICK
Head of Health Economics and Market Access
Cell and Gene Therapy Catapult
JAMES FRY
Partner and Head of Life Sciences
Mills & Reeve
RAJA SHARIF
Founder and Chief Executive Officer
ATMPS Ltd
LEN PATTENDEN
Chief Operating Officer
Ascend GCTx Ltd
ANDREEA IFTIMIA-MANDER
Director of Lifesciences
Biomatics
ANDREA CUSACK
CEO & Managing Director
leon-nanodrugs
FRASER McBLANE
Global Project Team Lead
Novartis
KAROLINA ZAPADKA
Investor
Parkwalk Advisors
ANDY LEWIN
Chief Business Officer
Ascend Gene and Cell Therapies
Cellular Growth | Tech to translate | Making it